These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23661602)

  • 1. Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question?
    Testoni B; Levrero M; Durantel D
    Gut; 2014 Jan; 63(1):3-4. PubMed ID: 23661602
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.
    Rotman Y; Noureddin M; Feld JJ; Guedj J; Witthaus M; Han H; Park YJ; Park SH; Heller T; Ghany MG; Doo E; Koh C; Abdalla A; Gara N; Sarkar S; Thomas E; Ahlenstiel G; Edlich B; Titerence R; Hogdal L; Rehermann B; Dahari H; Perelson AS; Hoofnagle JH; Liang TJ
    Gut; 2014 Jan; 63(1):161-9. PubMed ID: 23396509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy.
    Aghemo A; Rumi MG; De Nicola S; Colombo M
    Hepatology; 2010 Sep; 52(3):1170-1. PubMed ID: 20812363
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrahepatic interferon-stimulated gene responses: can they predict treatment responses in chronic hepatitis C infection?
    Shackel NA; McCaughan GW
    Hepatology; 2007 Nov; 46(5):1326-8. PubMed ID: 17969041
    [No Abstract]   [Full Text] [Related]  

  • 5. Alleles at rs4273729 in the chromosome 6 do not predict response to peg-interferon-α and ribavirin therapy in hepatitis C virus/HIV-1-coinfected patients.
    Franco S; Tural C; Clotet B; Martinez MA
    AIDS; 2012 Sep; 26(15):1973-4. PubMed ID: 22992578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peginterferon alpha and ribavirin therapy for difficult-to-treat chronic hepatitis C patients].
    Pawłowska M; Halota W
    Przegl Epidemiol; 2002; 56 Suppl 4():51-4. PubMed ID: 14750261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2].
    Znoyko OO; Dudina KR; Kozina AN; Kalininа OV; Yushchuk ND
    Ter Arkh; 2016; 88(5):84-85. PubMed ID: 27239933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic of Virologic Response to Pegylated Interferon and Ribavirin in Children With Chronic Hepatitis C Predicts the Effect of Treatment.
    Indolfi G; Nebbia G; Cananzi M; Maccabruni A; Zaramella M; D'Antiga L; Grisotto L; Azzari C; Resti M;
    Pediatr Infect Dis J; 2016 Dec; 35(12):1300-1303. PubMed ID: 27636721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients.
    van Vlerken LG; Huisman EJ; van Soest H; Boland GJ; Drenth JP; Siersema PD; Burger DM; van Erpecum KJ
    J Viral Hepat; 2012 Jan; 19(1):39-46. PubMed ID: 21114586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early virologic response in retherapy with pegylated interferon alpha-2B plus ribavirin in children with chronic hepatitis C].
    Pawłowska M; Palewicz E; Halota W
    Przegl Epidemiol; 2006; 60(1):71-7. PubMed ID: 16758742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between HCV RNA assays for week 24 HCV RNA determination during pegylated interferon-α/ribavirin treatment for chronic hepatitis C.
    Roomer R; van Vuuren AJ; Schutten M; Heijens A; Janssen HL; de Knegt RJ
    Antivir Ther; 2011; 16(5):771-4. PubMed ID: 21817199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early virological response in children with chronic hepatitis C treated with pegylated interferon and ribavirin.
    Kowala-Piaskowska A; Słuzewski W; Figlerowicz M; Mozer-Lisewska I
    Infection; 2007 Jun; 35(3):175-9. PubMed ID: 17565459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trials.
    Marcellin P; Cheinquer H; Curescu M; Dusheiko GM; Ferenci P; Horban A; Jensen D; Lengyel G; Mangia A; Ouzan D; Puoti M; Rodriguez-Torres M; Shiffman ML; Schmitz M; Tatsch F; Rizzetto M
    Hepatology; 2012 Dec; 56(6):2039-50. PubMed ID: 22706730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term viral response to interferon alpha 2b plus ribavirin in chronic hepatitis C patients during standard therapy].
    Adamek A; Adamek J; Juszczyk J; Bereszyńska I
    Przegl Epidemiol; 2007; 61(4):765-70. PubMed ID: 18572509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of treatment with pegylated interferon and ribavirin in children with chronic hepatitis C].
    Kowala-Piaskowska A; Figlerowicz M; Mozer-Lisewska I; Słuzewski W
    Przegl Epidemiol; 2005; 59(2):491-8. PubMed ID: 16190558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies to interferon-α and circulating interferon in patients with chronic hepatitis C non-responding to pegylated interferon plus ribavirin re-treated by pegylated interferon-α-2a and ribavirin (ANRS HC16 GAMMATRI substudy).
    Halfon P; Pérusat S; Bourlière M; Bronowicki JP; Trimoulet P; Benhamou Y; Leroy V; Marcellin P; Foucher J; Penaranda G; Chêne G; Couzigou P;
    J Med Virol; 2010 Dec; 82(12):2027-31. PubMed ID: 20981789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic and Peripheral CXCL10 Expression in Hepatitis C Virus-Infected Patients Treated With Telaprevir, Pegylated Interferon, and Ribavirin.
    Zeremski M; Dimova RB; Benjamin S; Penney MS; Botfield MC; Talal AH
    J Infect Dis; 2015 Jun; 211(11):1795-9. PubMed ID: 25512630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses.
    Meng P; Zhao S; Niu X; Fu N; Su S; Wang R; Zhang Y; Qiao L; Nan Y
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peginterferon and ribavirin for chronic hepatitis C.
    Hoofnagle JH; Seeff LB
    N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes of the serum adiponectin during treatment with peginterferon α-2a and ribavirin for chronic hepatitis C].
    Huang P; Yang YF; Xiong QF; Zhong YD
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):394-5. PubMed ID: 22988588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.